Land O’Lakes: Responses to and Potential Impact of the New FDA Guidance on Bioanalysis with Large Molecules (Marian Kelley)
ISO standards concept, quality medical service and certification, quality improvement certification, GMP Good Manufacturing Practice, medical pharmaceutical concept. Standard warranty
In collaboration with the event organizers, University of Wisconsin, Bioanalysis Zone is pleased to feature a presentation by Marian Kelley on ‘Responses to and Potential Impact of the New FDA Guidance on Bioanalysis with Large Molecules’ from the 15th Annual Land O’Lakes Bioanalytical Conference, July 21-24 2014.
More presentations from the 15th Land O’Lakes Bioanalytical Conference:
Biomarkers and Dealing with Endogeneous Analytics (Binodh DeSilva)
Biosimilars from a Clinical and Regulatory Perspective (Hazel Gorham)
